Novel Substituted Spiro-Ureas as Monoacylglycerol Lipase Inhibitors

This patent describes novel spiro-ureas as a novel class of monoacylglycerol lipase (MAGL) inhibitors. It provides details on the novel substituted spiro-ureas, pharmaceutical composition, and therapeutic applications for diseases associated with MAGL dysregulation.